In extremely rare cases, the use of this drug has led to the development of liver cancer, leukemia and even death of athletes. However, such cases are extremely rare, that is on a par with the powerful growth forces of the same growth and muscle mass. Average growth is 5-7 kg in 2 weeks. In addition, this steroid promotes water retention in muscle cells, making muscles even more massive and bloated. In addition, the accumulated liquid has a positive effect on the joints, therefore the increase of working weights and increase your training intensity will not affect the health of bones and ligaments.
Ligand Pharmaceuticals has patents filed for the manufacture and therapeutic use of certain compounds occupying several stated chemical structures, which are intended for use as selective androgen receptor modulators. The patent is filed under the following designations: US8519158 B2, US8865918, US9359285, US20070254875, US20140005186, US20150099720, and WO2005090282A1. The patents will expire on March 12, 2025. These patents effectively protect any future capitalization upon VK5211 in the market by Viking and Ligand through their licensing agreement.